SCHEMBL22025196

SCHEMBL22025196

c1ccc(-c2ccc(-c3nc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)nc(-c4ccccc4-n4c5ccccc5c5cc6ccccc6cc54)n3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ ATM Q13315 1/20 0.39
▸ PTGER4 P35408 1/20 0.36
▸ NPY5R Q15761 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.31
▸ AVPR1A P37288 1/20 0.31
▸ TSPO P30536 1/20 0.31
▸ HDAC4 P56524 1/20 0.31
▸ KMT2A Q03164 2/20 0.30
▸ IL1R1 P14778 1/20 0.30
▸ KDR P35968 1/20 0.30
▸ AKT1 P31749 1/20 0.30
▸ PDE6D O43924 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ MAPT P10636 1/20 0.30
▸ HTT P42858 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ CTDSP1 Q9GZU7 1/20 0.30
▸ HTR6 P50406 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22025205 0.99 KDM4E (0.40) KDM4EL3MBTL1ATMPTGER4NPY5R
SCHEMBL22024419 0.96 KDM4E (0.38) KDM4EL3MBTL1ATMPTGER4NPY5R
SCHEMBL22024426 0.96 KDM4E (0.39) KDM4EL3MBTL1ATMPTGER4ALDH1A1
SCHEMBL22025203 0.94 KDM4E (0.40) KDM4EL3MBTL1ATMPTGER4ALDH1A1
SCHEMBL22024255 0.94 KDM4E (0.38) KDM4EL3MBTL1ATMPTGER4NPY5R
SCHEMBL22024893 0.94 KDM4E (0.39) KDM4EL3MBTL1ATMPTGER4NPY5R
SCHEMBL24152003 0.93 KDM4E (0.45) KDM4EL3MBTL1ATMPTGER4NPY5R
SCHEMBL22024215 0.93 KDM4E (0.38) KDM4EL3MBTL1ATMPTGER4NPY5R
SCHEMBL22024456 0.93 KDM4E (0.38) KDM4EL3MBTL1ATMPTGER4NPY5R
SCHEMBL22883704 0.92 RAC2 (0.34) KDM4EL3MBTL1ATMPTGER4NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667626-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-06-06 — — US disclosed
US-11667626-B2 Compound and organic light-emitting device comprising same LG CHEM, LTD. (KR) 2023-06-06 — — US disclosed
US-20200165234-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667626-B2 Compound and organic light-emitting device comprising same CRY1, CRY2, PER2 KDM4E 2542/4885L3MBTL1 863/4885ATM 3002/4885
US-20200165234-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CRY2, PER2 KDM4E 2542/4885L3MBTL1 863/4885ATM 3002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback